AltPep Corporation
- | Biotech or pharma, therapeutic R&D
- | Diagnostics
AltPep is a Seattle-based biotech developing groundbreaking treatments and diagnostics for amyloid diseases by targeting early molecular triggers: alpha sheet oligomers. Initial focus is Alzheimer's and Parkinson's, with ATTR and T2D in research.
Address
WashingtonUnited States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}